Related Experiment Video

Updated: Jul 13, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase

Sheldon Holder1, Michael Lilly, Milton L Brown

  • 1Center for Molecular Biology & Gene Therapy, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA.

Bioorganic & Medicinal Chemistry
|July 20, 2007
PubMed

Insights

This study developed a predictive model for PIM-1 kinase inhibitors using Comparative Molecular Field Analysis (CoMFA). The model reveals key steric and electrostatic properties for designing effective small-molecule drugs targeting cancers like lymphoma and leukemia.

Area of Science:

  • Medicinal Chemistry
  • Structural Biology
  • Computational Drug Design

Background:

  • PIM-1 kinase, a serine/threonine kinase, is a validated target in human malignancies such as lymphomas, leukemias, and prostate cancer.
  • Dysregulation of PIM-1 kinase activity is a significant factor in the development and progression of various cancers.
  • Flavonoids represent a promising class of small molecules with potential inhibitory activity against PIM-1 kinase.

Purpose of the Study:

  • To generate a predictive Quantitative Structure-Activity Relationship (QSAR) model for flavonoid inhibitors of PIM-1 kinase.
  • To elucidate the critical steric and electrostatic features governing flavonoid binding to the PIM-1 kinase active site.
  • To facilitate the rational design of novel, potent small-molecule inhibitors for PIM-1 kinase.

Main Methods:

  • Comparative Molecular Field Analysis (CoMFA), a 3D-QSAR technique, was employed to analyze a dataset of 15 flavonoid inhibitors.
  • Ligands were aligned de novo based on a common substructure to generate the CoMFA model.
  • Partial Least Squares (PLS) regression was used to correlate structural features with inhibitory potency (-logIC50).

Main Results:

  • A robust CoMFA model was developed with a non-cross-validated q² of 0.805 for the training set (n=15).
  • Steric analysis indicated a preference for planar molecules in the PIM-1 binding site, suggesting a sterically hindered pocket.
  • Electrostatic mapping revealed that positive charges near C8 and negative charges near C4' on flavonoids enhance binding affinity.
  • The model accurately predicted the potency of an independent test set (n=6) with a q² of 0.825.

Conclusions:

  • The generated CoMFA model is the first predictive tool for rational design of PIM-1 kinase inhibitors.
  • Understanding the steric and electrostatic requirements of the PIM-1 binding site can guide the development of more effective anticancer agents.
  • The study validates the utility of 3D-QSAR in drug discovery for kinase inhibitors.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...